|
| 大麻素1型受体参与疼痛调节机制的研究进展 |
| Research progress of cannabinoid type 1 receptors involved in pain modulation mechanism |
| |
| DOI：10.12089/jca.2024.06.017 |
| 中文关键词: 大麻素1型受体 疼痛 镇痛机制 内源性大麻素 |
| 英文关键词: Cannabinoid type 1 receptor Pain Analgesic mechanism Endogenous cannabinoid |
| 基金项目:甘肃省科技计划项目（21JR7RA586，20JR10RA435） |
|
| 摘要点击次数: 750 |
| 全文下载次数: 788 |
| 中文摘要: |
| 大麻素1型受体（CB1R）是近年来研究较为广泛的内源性大麻素受体之一，在中枢和外周神经系统均有表达。CB1R位于突触前膜，通过逆行抑制性突触传递调节神经递质的释放，是治疗疼痛的有效靶点。激活CB1R对伤害性、病理性和炎性疼痛均具有镇痛效应，拮抗CB1R可引起疼痛敏化。本文通过对CB1R结构功能、信号转导、镇痛机制方面进行综述，为进一步了解疼痛的病理生理学机制及探索更优疼痛治疗方法提供参考。 |
| 英文摘要: |
| Cannabinoid type 1 receptor (CB1R) is one of the most widely studied endocannabinoid receptors in recent years, which is expressed in both central and peripheral nerve systems. CBIR is located in the presynaptic membrane, and regulates the release of neurotransmitters through retrograde inhibitory synaptic transmission, which is an effective target for the treatment of pain. Activation of CB1R has analgesic effect on injurious, pathological, and inflammatory pain, and antagonism of CB1R can cause pain sensitization. This article describes CB1R from the aspects of structure and function, signal transduction, and analgesic mechanism, so as to provide reference for further understanding the pathophysiology of pain and exploring better pain treatment methods． |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
